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Supplementary Figure 1. a Pathogenwatch collection tree of 118 diverse S. Typhi genomes (dataset I) 
representing 62 genotypes (tree labels). b Pathogenwatch collection tree of 138 closely-related genomes 
from a clonal expansion within East Africa (dataset II). The tree nodes are labelled by country of isolation. 
The scale bars represent the number of SNP differences.  
 
  
Supplementary Figure 2. a Three-dimensional multidimensional scaling (MDS) plot of pairwise tree 
distances from dataset I (118 genomes), and b Two-dimensional MDS plot of pairwise tree distances from 
dataset II (138 genomes), both generated with Treescape. Trees were generated with four methods: 1) 
Pathogenwatch (purple); 2) Maximum likelihood on 9112 SNPs identified on an alignment of 3996 
concatenated core genes estimated with roary (best tree, red); 3) Neighbour joining on the same alignment 
in 2) (orange); and 4) Maximum likelihood on 8598 SNPs called on a CT18-guided alignment (best tree, 
green). Five hundred bootstrap replicates were computed for each of the methods 2 (pink) and 4 (lime 
green). The inset in a unveils the position of the best tree from method 4 (green). The matrix shows the 
pairwise distances between the trees from methods 1-4 for dataset I (below diagonal) and dataset II (above 
diagonal). c Tanglegram comparison of the Pathogenwatch tree of 43 genomes from subclade 3.2.1 (right) 











Supplementary Figure 3. The Typhi Pathogenwatch population Tree of 19 reference genomes, inferred 
from 2409 polymorphic sites found in 1639 of the 3916 core gene families. The numbers in parenthesis 
indicate the number of user genomes that have been sub-clustered with each reference in the tree. The 
numbers in brackets indicate the number of public genomes available on each subtree, which are also 
clustered with the user genomes. 
Supplementary Figure 4. Geographic distribution of public S. Typhi genomes available in Pathogenwatch. The size of the markers is proportional to 
the number of genomes in each country. The pie charts show the relative abundance of the four major clades per country. The visualization was 
created with Tableau Desktop v2018.3. 
 
  
Supplementary Figure 5. Temporal distribution (left) and frequency (right) of the genotypes in the Typhi Pathogenwatch public collection of 
genomes. Genotypes were grouped by clade (e.g. 4.2) with the exception of 4.3, which was further discriminated into subclades. The markers on the 
timeline were coloured by the major clade they belong to, and their size is proportional to the number of genomes. The bar chart show the frequency 
of the genotypes, coloured by the major clade they belong to. Isolates collected before 1970 were excluded from the graphs. The visualization was 
created with Tableau Desktop v2018.3. 
 
 
Supplementary Figure 6. Distribution of minimum inhibitory concentration (MIC) values (mg L-1) 
for ciprofloxacin in a collection of 889 S. Typhi isolates with different combinations of genetic 
mechanisms that are known to confer resistance to this antibiotic. Dashed horizontal lines on the 
violin plots mark the CLSI clinical breakpoint for ciprofloxacin. Point colours inside violins 
represent the genotypic AMR prediction by Pathogenwatch on each combination of mechanisms. 
Bar plots on the top show the abundance of genomes with each combination of mechanisms. Bar 
colours represent the differences between the predicted and the observed SIR (e.g. red for a 
predicted susceptible mechanism when the observed phenotype is resistant). S = susceptible, I = 















































Supplementary Figure 7. Distribution of predicted (a) ciprofloxacin-resistant (CIP), (b) MDR 
(resistant to ampicillin, chloramphenicol, sulfamethoxazole, and trimethoprim), and (c) XDR (MDR 
with additional resistance to ciprofloxacin, and extended-spectrum cephalosporins) S. Typhi on the 
map and tree of 4389 genomes. Tree nodes are coloured red (resistant), yellow (intermediate), or 
white (no resistance determinants found). The map pie charts display the proportion of 
resistant/intermediate genomes at each location. The expandable pie chart at the top-left corner of 









Supplementary Figure 8. Distribution of plasmid replicon marker types across the 4389 public genomes in Typhi Pathogenwatch. a Number of 
replicon markers per year interval. The genomes from isolates collected before 1990 were excluded. b Distribution of replicon marker types across 
the different predicted resistance profiles grouped as in Supplementary Figure 4. c Geographical distribution. d Distribution of replicon types across 













Supplementary Table 1. Collections of S. Typhi genomes included in Pathogenwatch at the time of writing. The availability of strain-level 
antimicrobial susceptibility testing (AST) data and of MIC values for ciprofloxacin is indicated. 
 
Collection name PMID No. of Genomes Location 
AST performed/ 
data used for 
concordance 
CIP MIC data 
available Reference 
Ahmad et al. (2017) 28254988 1 Malaysia yes / no no (1) 
Ashton et al. (2016) 27069781 513 UK (Travel multi) no no (2) 
Baker et al. (2015) 26411565 37 NA no no (3) 
Britto et al. (2018) 29684021 192 Nepal yes / yes no (4) 
Britto et al. (2020) 31665304 94 India yes / yes no (5) 
Burnsed et al. (2018) 30236166 30 USA  (Travel Marshall Islands) yes / no no (6) 
Djeghout et al. (2018) 29616895 1 Bangladesh yes / yes yes (7) 
Dyson et al. (2017) 28060810 45 Thailand no no (8) 
Gul et al. (2017) 29051234 1 Pakistan yes / no no (9) 
Hendriksen et al. (2015) 25392358 22 Zambia yes / no no (10) 
Hendriksen et al. (2015) 25428145 2 Netherlands and Norway (Travel Philippines) yes / yes yes (11)  
Hooda et al. (2019) 31730615 12 Bangladesh yes / yes no (12) 
Ingle et al. (2019) 31513580 524 UK (Travel multi) yes (N=173) / yes yes (13) 
Klemm et al. (2018) 29463654 100 Pakistan yes / yes no (14) 
Matono et al. (2017) 29255729 93 Japan (Travel multi) yes / yes no (15) 
Oo et al. (2019) 31225619 39 Myanmar yes / yes yes (16) 
Park et al. (2018) 30504848 249 Africa multi no no (17) 
Pham Thanh et al. (2016) 26974227 78 Nepal yes / yes yes (18) 
Phoba et al. (2017) 29136410 1 DR Congo yes/no no (19) 
Pragasam et al. (2020) 32003431 194 India yes (N=30) / yes no (20) 
Rodrigues et al. (2017) 25961941 3 India yes / no no (21) 
Sah et al. (2019) 31872221 2 India yes / yes yes (22) 
Tanmoy et al. (2018) 32003431 536 Bangladesh yes / yes yes (23) 
Wong et al. (2015) 25961941 1822 Multi no no (24) 
Wong et al. (2016) 27703135 99 Multi no no (25) 




Supplementary Table 2. List of genetic AMR determinants in Typhi Pathogenwatch. Effect: R = 
Resistance, I = Intermediate resistance (decreased susceptibility). Genes and mutations in bold 
type have been demonstrated to have a role on AMR in S. Typhi, the remaining mechanisms are 
of emerging importance in Gram negative bacteria. Pathogenwatch Library 1: S. Typhi AMR (27), 
2: ESBL (28), 3: Carbapenemases (29), 4: Colistin resistance (30) 
 




Phenicols Chloramphenicol (CHL) catA1 R 1  (31) 
    cmlA R 1 (32) 
Fluoroquinolones Ciprofloxacin (CIP) qnrS, qnrB, qnrA, qnrD I 1  (33) 
  gyrA S83F, S83Y, D87N, D87Y, 
D87A, D87G, D87V I 1  (33, 34) 
  gyrB S464F, S464Y, Q465R, 
Q465L I 1  (33) 
  parC S80I, E84G, E84K I 1  (33) 
    parE L416F, D420N I 1  (33, 35, 36) 
Sulfonamides Sulfamethoxazole (SXM) sul1, sul2 R 1  (32) 
Folate Pathway 
Inhibitors Trimethoprim (TMP) 
dfrA1, dfrA5, dfrA7, drfA14, 
dfrA15, dfrA17, dfrA18 R 1  (32) 
  Tetracycline (TCY) tetA(A), tetA(B), tetA(C), tetA(D) R 1  (31) 
Macrolides Azithromycin (AZM) ermA, ermB, ermC R 1   
  ereA, ereB R 1   
  mefA R 1   
  mphA, mphB R 1   
  msrA, msrD R 1   
    acrB R717Q R 1  (12) 
Penicillins Ampicillin (AMP) blaTEM-1 R 1  (31) 
  blaOXA-1, blaOXA-7 R 1   
    Determinants of CEP and MEM R 2,3 
Cephalosporins Extended-spectrum cephalosporins (CEP) blaCMY-2 R 1   
  ampC R 1   
  blaCTX-M R 2  (37) 
  blaSHV R 2  (38) 
  blaOXA-11, blaOXA-15 R 2   
    blaTEM-10, blaTEM-124 R 2   
  Determinants of MEM R 3 
Carbapenems Meropenem (MEM) blaAIM R 3   
  blaBIC R 3   
  blaDIM R 3   
  blaGES R 3  
  blaGIM R 3   
  blaIMI R 3   
  blaIMP R 3   
  blaKPC R 3   
  blaLMB R 3   
  blaNDM R 3  
  blaNMCA R 3   
  blaOXA-48 like R 3   
  blaSIM R 3   
  blaSPM R 3   
    blaVIM R 3   
Polymixins Colistin (CST) mcr-12345678 R 4   
 
  
Supplementary Table 3. Distribution of known fluoroquinolone (Flq) resistance determinants (genes and 
mutations) in the 4389 public genomes in Pathogenwatch, and the linked genomic prediction of ciprofloxacin 




No. of Flq 
resistance 
genes 
No. of Flq 
resistance 
mutations 
Flq resistance determinants  





1939 0 0 None Susceptible 
1219 0 1 gyrA_S83F Intermediate 
421 0 1 gyrA_S83Y Intermediate 
80 0 1 gyrB_S464F Intermediate 
68 0 1 gyrA_D87N Intermediate 
26 0 1 gyrA_D87G Intermediate 
16 0 1 gyrB_S464Y Intermediate 
14 0 1 gyrA_D87Y Intermediate 
1 0 1 gyrA_D87V Intermediate 
1 0 1 gyrA_D87A Intermediate 
1 0 1 gyrB_Q465L Intermediate 
158 0 2 gyrA_S83F,parE_D420N Intermediate 
27 0 2 gyrA_S83F,parC_E84G Intermediate 
23 0 2 gyrA_S83F,parE_L416F Intermediate 
7 0 2 gyrA_S83F,parC_E84K Intermediate 
4 0 2 gyrA_S83F,parC_S80I Intermediate 
3 0 2 gyrA_S83Y,parE_D420N Intermediate 
1 0 2 gyrB_S464F,gyrB_Q465L Intermediate 
1 0 2 gyrA_D87N,gyrB_Q465L Intermediate 
192 0 3 gyrA_S83F,gyrA_D87N,parC_S80I Resistant 
9 0 3 gyrA_S83F,gyrA_D87G,parC_E84K Intermediate 
6 0 3 gyrA_S83F,gyrB_Q465R,parE_D420N Intermediate 
5 0 3 gyrA_S83F,gyrA_D87V,parC_S80I Intermediate 
2 0 3 gyrA_S83F,gyrA_D87G,parC_S80I Intermediate 
1 0 3 gyrA_S83F,gyrA_D87N,parC_E84K Intermediate 
1 0 3 gyrA_S83Y,gyrA_D87G,parC_S80I Intermediate 
1 0 3 gyrA_S83F,gyrA_D87G,parE_D420N Intermediate 
1 0 3 gyrA_S83F,gyrA_D87G,parC_E84G Intermediate 
3 1 0 qnrS Intermediate 
87 1 1 qnrS,gyrA_S83F Resistant 
64 1 1 qnrS,gyrA_S83Y Resistant 
2 1 1 qnrB,gyrA_S83F Resistant 
2 1 2 qnrB,gyrA_S83F,parC_E84K Resistant 
3 1 3 qnrB,gyrA_S83F,gyrA_D87N,parC_S80I Resistant 
 
  
Supplementary Table 4. Reference genomes used to compute the Pathogenwatch S. Typhi core genome library (N=26) and the population tree 
(N=19).  
 






















E02-1180 India 2002 2 0.0.3 4838914 4793071 4 0 52.1 100 ERR581073, ERR581085 PRJEB5919 25961941 yes yes 





1976 8 1.1.3 4934685 4780549 3 0 52.1 100 ERR601541, ERR601549 PRJEB5919 25961941 yes yes 
M326 Unknown 1939 2 1.2.1 4775555 204340 47 8 52 100 ERR279243 PRJEB3255 26411565 no yes 
11909_3 Mexico 2011 2 2.0.2 4811824 4753305 4 0 52 100 ERR584382, ERR584388 PRJEB5919 25961941 yes yes 




PRJEB5919 25961941 yes no 
ERL024120 Indonesia 2002 2138 2.1.2 4811886 4811886 1 0 52.1 100 ERR581076, ERR581091 PRJEB5919 25961941 yes yes 
M223 Unknown 1939 2 2.1.7 4849011 4806333 3 0 52.1 100 ERR581077, ERR581088 PRJEB5919 25961941 yes no 
80-2002 Madagascar 1980 2 2.2 5061131 4819925 4 0 52.1 100 ERR601542, ERR601550 PRJEB5919 25961941 yes no 
ERL114000 Nepal 2011 2 2.2 4776059 4776059 1 0 52.1 100 ERR581075, ERR581086 PRJEB5919 25961941 yes no 
UI4692 Laos 2004 2 2.2.2,2.2.3 4707798 185395 43 0 52.1 100 ERR331348 PRJEB3215 25961941 no yes 
ERL103914 South America 2010 2 2.3.2 4789623 4789623 1 0 52.1 100 
ERR581074, 
ERR581092 PRJEB5919 25961941 yes no 
ST1921-06 Argentina 2006 2 2.3.3 4718006 204238 42 0 52.1 100 ERR353335 PRJEB3215 25961941 no yes 
LNT1360 Laos 2010 2218 2.4 4794285 206322 40 2 52.1 100 ERR326664 PRJEB3215 25961941 yes no 
D50739 Malawi 2009 2 2.4.1 4704071 206289 45 24 52.1 100 ERR279161 PRJEB3215 25961941 yes yes 
E98-0664 Kenya 1998 2 2.5 4764488 4752533 3 0 52.1 100 ERR601554, ERR601551 PRJEB5919 25961941 yes yes 
H12ESR00755-
001A Philippines 2012 1 3 4814227 4802146 2 0 52.1 100 
ERR581080, 
ERR581089 PRJEB5919 25961941 yes yes 




PRJEB5919 25961941 yes no 
404Ty Indonesia 1983 2 3.1.2 4890679 4807711 6 0 52 100 ERR581078, ERR581090 PRJEB5919 25961941 yes yes 
CT18 Vietnam 1993 2 3.2.1 5133713 4809037 3 0 51.9 100 GCA_000195995.1 PRJNA236 11677608 yes yes 
ERL041834 India 2004 2 3.3 4892436 4675147 5 0 52.1 100 ERR581081, ERR581083 PRJEB5919 25961941 yes yes 
H12ESR04734-
001A India 2012 2 3.3 4943859 4876386 5 0 52.1 100 
ERR581099, 
ERR581105 PRJEB5919 25961941 yes no 
002168 Cambodia 2010 1 3.4 4764266 217780 42 2 52.1 100 ERR360747 PRJEB3215 25961941 yes no 
LNT1148 Laos 2001 1 3.4 4743503 204320 46 2 52.1 100 ERR340779 PRJEB3215 25961941 yes yes 
ERL024919 Samoa 2002 1 3.5.4 4805266 4784637 2 0 52.1 100 ERR581094, ERR581102 PRJEB5919 25961941 yes no 
H12ESR00394-
001A Samoa 2012 1 3.5.4 4808147 4808147 1 0 52.1 100 
ERR581095, 
ERR581103 PRJEB5919 25961941 yes yes 
Ty2 Russia 1916 1 4.1 4791961 4791961 1 11 52.1 100 GCA_000007545.1 PRJNA371 12644504 yes yes 
ERL072973 Fiji 2007 1 4.2.2 4806043 4789877 2 0 52.1 100 ERR581097, ERR581107 PRJEB5919 25961941 yes yes 
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